Specialty Care Programs
Certain complex medical conditions require expensive ongoing treatments for which a Provider Network discount simply isnít enough to contain costs. For these conditions, ACS has developed a suite of Specialty Care Programs that includes best-in-class pricing from our provider partners. Each program focuses on guiding patients through the management of the treatment process so that they receive complete, well-rounded care. With our programs, patients and employers can save up to 50 percent on costs for these treatments.
A program focused on Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD)
While there are many programs in the marketplace to manage the cost of dialysis, DiaSource takes a unique approach by focusing on the continuum of needs for the dialysis patient. We start with the belief that each patient has a unique set of circumstances that must be incorporated into the overall solution. Together with our partners, we identify the CKD patients with a given employer population and take steps necessary to manage their disease process. Once a patient has progressed to ESRD and requires dialysis treatment, we identify the most appropriate treatment setting.
EyeOn Specialty Drug Therapy
A program focused on hemophilia and IVIG patients
Specialty drug costs are on the rise and employers are struggling to find ways, other than simply securing a drug rate, to manage this expense. The EyeOn Specialty Drug Therapy is a comprehensive program that focuses on ALL cost factors and clinical drivers impacting the healthcare spend. This program promotes clinical effectiveness, drug utilization, and adherence compliance management, as well as optimizes site of care and controls medical waste to drive more favorable clinical and financial outcomes.
Obstructive Sleep Apnea Program
A program focused on the testing and treatment of Obstructive Sleep Apnea (OSA)
Most employers don't recognize the total costs associated with the diagnosis and treatment of OSA because the medical claims are relatively small and some costs, such as absenteeism, are not associated with the disease. In any given population, 15% will be tested for sleep disorders in a given year, with the majority diagnosed and treated for OSA. ACS looks at the entire continuum of care for sleep disorders by managing both the costs associated with testing and the costs associated with treatment and compliance. The resulting financial savings to an employer may include savings on overall medical spend, reductions in lost time and reductions in disability costs.